SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-012669
Filing Date
2018-08-29
Accepted
2018-08-28 18:46:01
Documents
6
Period of Report
2018-08-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 77285
2 ex3-1.htm EX-3.1 40891
3 ex99-1.htm EX-99.1 143558
4 ex99-2.htm EX-99.2 47013
5 ex99-3.htm EX-99.3 60397
6 ex99-4.htm EX-99.4 32444
  Complete submission text file 0001493152-18-012669.txt   402897
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 181042716
SIC: 2835 In Vitro & In Vivo Diagnostic Substances